China Universal Asset Management »

Apellis Pharmaceuticals shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.4M 23k 58.80
2023-12-31 $821k 14k 59.88
2023-09-30 $115k 3.0k 37.98
2023-06-30 $213k 2.3k 90.99
2023-03-31 $156k 2.4k 65.93
2022-12-31 $58k 1.1k 51.65
2022-09-30 $70k 1.0k 68.03

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Vertex Pharmaceuticals Common Stock (VRTX)
Amgen Common Stock (AMGN)
Servicenow Common Stock (NOW)
Gilead Sciences Common Stock (GILD)
Regeneron Pharmaceuticals Common Stock (REGN)
Alphabet Inc-cl A Common Stock (GOOGL)
Adobe Common Stock (ADBE)
Broadcom Common Stock (AVGO)
Visa Inc-class A Shares Common Stock (V)
Apple Common Stock (AAPL)
Uber Technologies Common Stock (UBER)

View all positions for China Universal Asset Management

Top funds holding Apellis Pharmaceuticals

Wellington Management Company
EcoR1 Capital
venBio Select Advisor
Vanguard Group
Jennison Associates
Octagon Capital Advisors
Jpmorgan Chase & Co
T. Rowe Price Associates
Assenagon Asset Management
Logos Global Management
Boxer Capital
Artal Group
Citadel Advisors
Caption Management
Norges Bank Investment Management

View all funds holding Apellis Pharmaceuticals